CIPRAMIL

This brand name is authorized in Australia, Brazil, Estonia, Germany, Ireland, Israel, Netherlands, New Zealand, Poland, South Africa, UK.

Active ingredients

The drug CIPRAMIL contains one active pharmaceutical ingredient (API):

1	Citalopram UNII I1E9D14F36 - CITALOPRAM HYDROBROMIDE
	Citalopram is the most Selective Serotonin Reuptake Inhibitor (SSRI) yet described, with no, or minimal, effect on noradrenaline (NA), dopamine (DA) and gamma aminobutyric acid (GABA) uptake.
	Read more about Citalopram

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CIPRAMIL Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB04	Citalopram	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8220P
BR	Câmara de Regulação do Mercado de Medicamentos	524200102116311
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01229667, 01229673, 01229696, 01265700, 01265717, 02459122, 02459139, 02459145, 02558717, 03792728, 03792734, 03793113, 07528431, 07528448, 08691972
EE	Ravimiamet	1070525
GB	Medicines & Healthcare Products Regulatory Agency	138495, 14215, 144960, 144962, 161491, 27300
IE	Health Products Regulatory Authority	18304, 18310, 18351, 18359, 18382, 18395
IL	מִשְׂרַד הַבְּרִיאוּת	3340, 6498
NL	Z-Index G-Standaard	14271079
NL	Z-Index G-Standaard, PRK	44083, 44091, 52485
NZ	Medicines and Medical Devices Safety Authority	7804
PL	Rejestru Produktów Leczniczych	100001120
ZA	Health Products Regulatory Authority	29/1.2/0232